Our findings suggest that inhibiting these miRNAs by antisense oligonucleotides might be an approach to correct hepatic CYP3 dysregulation in cirrhosis, although admittedly the clinical relevance of such a strategy is debatable. The gene discussed is PPIF; the disease is Cirrhosis.